Robbins LLP Reminds Investors of Oddity Tech Ltd. of Upcoming Lead Plaintiff Deadline – ODD Stockholder with Significant Losses Should Contact Robbins LLP Robbins LLP is Investigating Allegations that Oddity Tech Ltd. (ODD) Misled Investors Regarding its AI Technology and Capabilities

LAVA Therapeutics Receives FDA Orphan Drug Designation for LAVA-051 for the Treatment of Chronic Lymphocytic Leukemia UTRECHT, The Netherlands and PHILADELPHIA, Oct. 15, 2021 (GLOBE NEWSWIRE) -- LAVA Therapeutics N.V. (Nasdaq: LVTX), a clinical-stage biotechnology company, today announced that the U.S. Food and...